Biofermin Pharmaceutical. (4517.TSE) Q4 2019 Earnings

30JanExpected
Q1 2019
Q2 2019
Q3 2019
Q4 2019
40.32
51.14
61.96
72.78

Details

Expected EPS
N/A
Actual EPS
72.7765
Surprise EPS
72.78
Surprise Percent
+∞%

Description

Biofermin Pharmaceutical. (4517.TSE) has reported earnings of 72.7765 per share for Q4 2019.

0 Comments

Share your thoughts